
Laxatives Market Report 2026
Global Outlook – By Type (Hypertonic Laxative, Lubricating Laxative, Stimulant Laxative, Swelling Laxative, Other Types), By Formulation (Tablets, Powder, Liquid, Suppositories, Gels), By Applications (Chronic Constipation, Irritable Bowel Syndrome (IBS), Post-Surgery Recovery, Weight Loss And Detox), By End User (Hospitals, Clinics, Retail Pharmacies, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Laxatives Market Overview
• Laxatives market size has reached to $8.39 billion in 2025 • Expected to grow to $12.49 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Surge In Gastric Disorders Fueling The Growth Of The Market Due To Rising Prevalence And Associated Digestive Complications • Market Trend: Next-Gen Digestive Aid Offers Effective Relief Without Stimulant Risks • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Laxatives Market?
Laxatives are substances that help stimulate bowel movements or loosen stool to relieve constipation. They are commonly used to treat temporary digestive issues and promote regularity. Laxatives work through different mechanisms, such as softening stool, increasing bowel movement frequency, or stimulating intestinal muscles. The main types of laxatives include hypertonic laxatives, lubricating laxatives, stimulant laxatives, volumetric laxatives, swelling laxatives, and others. A hypertonic laxative is a type of laxative that draws water into the intestines through osmosis to stimulate bowel movements. It comes in formulations such as tablets, powder, liquid, suppositories, and gels. The applications include chronic constipation, irritable bowel syndrome (IBS), post-surgery recovery, and weight loss and detox, catering to end users such as hospitals, clinics, retail pharmacies, and others.
What Is The Laxatives Market Size and Share 2026?
The laxatives market size has grown strongly in recent years. It will grow from $8.39 billion in 2025 to $9.11 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to dietary fiber deficiency, sedentary lifestyles, aging population, hospital constipation management, OTC drug accessibility.What Is The Laxatives Market Growth Forecast?
The laxatives market size is expected to see strong growth in the next few years. It will grow to $12.49 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to preventive digestive health focus, clean-label laxative demand, e-commerce pharmacy growth, IBS prevalence increase, pediatric and geriatric formulation innovation. Major trends in the forecast period include rising demand for OTC digestive solutions, growth of fiber-based and natural laxatives, increased awareness of gut health, expansion of online pharmacy sales, product innovation in gentle formulations.Global Laxatives Market Segmentation
1) By Type: Hypertonic Laxative, Lubricating Laxative, Stimulant Laxative, Swelling Laxative, Other Types 2) By Formulation: Tablets, Powder, Liquid, Suppositories, Gels 3) By Applications: Chronic Constipation, Irritable Bowel Syndrome (IBS), Post-Surgery Recovery, Weight Loss And Detox 4) By End User: Hospitals, Clinics, Retail Pharmacies, Other End-Users Subsegments: 1) By Hypertonic Laxative: Saline Laxatives, Osmotic Laxatives, Fleet Phospho-soda, Lactulose 2) By Lubricating Laxative: Mineral Oil, Glycerin Suppositories, Emollient Enemas 3) By Stimulant Laxative: Bisacodyl, Senna (Sennosides), Castor Oil, Sodium Picosulfate 4) By Swelling Laxative: Psyllium Husk, Methylcellulose, Calcium Polycarbophil, Bran 5) By Other Types: Enemas, Suppositories, Herbal Laxatives, Probiotic-Based LaxativesWhat Is The Driver Of The Laxatives Market?
The rising prevalence of gastric disorders is expected to propel the growth of the laxatives market going forward. Gastric disorders refer to medical conditions that affect the stomach’s function and structure, causing symptoms such as pain, indigestion, and inflammation. The prevalence of gastric disorders is rising due to the increasing consumption of processed and fast foods. These foods often disrupt gut health by promoting inflammation and acid imbalance. Laxatives help manage gastric disorders by promoting bowel movements, relieving constipation, and reducing discomfort caused by digestive blockages. For instance, in February 2025, according to Cancer Australia, an Australia-based government agency, in 2023, an estimated 2,576 new stomach cancer cases were diagnosed, with a lifetime diagnosis risk by age 85 of 0.85% overall (1.1% for males and 0.61% for females). Therefore, the rising prevalence of gastric disorders is driving the growth of the laxatives industry.Key Players In The Global Laxatives Market
Major companies operating in the laxatives market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Reckitt Benckiser Group plc, Bausch Health Companies Inc., Nestlé Health Science, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Purdue Pharma L.P., Boiron S.A., Ironwood Pharmaceuticals Inc., Ferring Pharmaceuticals, C.B. Fleet Company Inc.Global Laxatives Market Trends and Insights
Major companies operating in the laxatives market are focusing on developing advanced formulations, such as osmotic laxatives, to improve digestive health results while meeting customers desire for safer, non-habit-forming options. Osmotic laxatives are non-stimulant substances that suck water into the intestines, softening stool and promoting bowel movements. They commonly contain polyethylene glycol (PEG) or lactulose. For instance, in June 2024, Glenmark Pharmaceuticals, an India-based pharmaceutical company, launched LaxaGo, an over-the-counter osmotic laxative. LaxaGo features a polyethylene glycol (PEG) 3350 formulation with balanced electrolytes for effective yet gentle relief, improved palatability with a neutral taste profile to enhance patient compliance, and a non-stimulant mechanism that prevents dependency risks associated with long-term use.What Are Latest Mergers And Acquisitions In The Laxatives Market?
In June 2023, Atlantis Consumer Healthcare Inc., a US-based provider of patient engagement solutions, acquired Avrio Health brands Senokot, Colace, Betadine, and SlowMag for an undisclosed amount. This acquisition aims to expand Atlantis's portfolio in digestive wellness and consumer healthcare. By incorporating these trusted brands, Atlantis plans to deliver effective, high-quality over-the-counter health products. Vrio Health is a US-based brand known for providing solutions addressing digestive health, infection prevention, and other wellness needs.Regional Insights
North America was the largest region in the laxatives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Laxatives Market?
The laxatives market consists of sales of prokinetic agents, herbal and natural laxatives, suppositories, and enemas (local delivery forms). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Laxatives Market Report 2026?
The laxatives market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the laxatives industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Laxatives Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $9.11 billion |
| Revenue Forecast In 2035 | $12.49 billion |
| Growth Rate | CAGR of 8.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Formulation, Applications, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Reckitt Benckiser Group plc, Bausch Health Companies Inc., Nestlé Health Science, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Purdue Pharma L.P., Boiron S.A., Ironwood Pharmaceuticals Inc., Ferring Pharmaceuticals, C.B. Fleet Company Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
